Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
Standard
Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study. / Schmitges, Jan; Karakiewicz, P I; Sun, M; Abdollah, F; Budäus, Lars; Isbarn, Hendrik; Bianchi, M; Trinh, Q-D; Schlomm, Thorsten; Chun, Felix; Graefen, Markus; Steuber, Thomas.
in: EJSO-EUR J SURG ONC, Jahrgang 38, Nr. 7, 7, 07.2012, S. 624-629.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
AU - Schmitges, Jan
AU - Karakiewicz, P I
AU - Sun, M
AU - Abdollah, F
AU - Budäus, Lars
AU - Isbarn, Hendrik
AU - Bianchi, M
AU - Trinh, Q-D
AU - Schlomm, Thorsten
AU - Chun, Felix
AU - Graefen, Markus
AU - Steuber, Thomas
N1 - Copyright © 2012 Elsevier Ltd. All rights reserved.
PY - 2012/7
Y1 - 2012/7
N2 - The 2011 European Association of Urology (EAU) guidelines for prostate cancer recommend a pelvic lymph node dissection (PLND) at radical prostatectomy (RP) in all individuals with a nomogram predicted lymph node invasion (LNI) risk of >7%.
AB - The 2011 European Association of Urology (EAU) guidelines for prostate cancer recommend a pelvic lymph node dissection (PLND) at radical prostatectomy (RP) in all individuals with a nomogram predicted lymph node invasion (LNI) risk of >7%.
KW - Adult
KW - Germany
KW - Humans
KW - Male
KW - Aged
KW - Middle Aged
KW - Practice Guidelines as Topic
KW - Risk Factors
KW - Europe
KW - Reproducibility of Results
KW - Lymphatic Metastasis
KW - Pelvis
KW - Predictive Value of Tests
KW - Prognosis
KW - Risk Assessment
KW - Neoplasm Staging
KW - Societies, Medical
KW - Calibration
KW - Neoplasm Grading
KW - Prostate-Specific Antigen/blood
KW - Nomograms
KW - Prostatectomy
KW - Tumor Markers, Biological/blood
KW - Lymph Node Excision
KW - Confounding Factors (Epidemiology)
KW - Lymph Nodes/pathology
KW - Prostatic Neoplasms/immunology/pathology/surgery
KW - Adult
KW - Germany
KW - Humans
KW - Male
KW - Aged
KW - Middle Aged
KW - Practice Guidelines as Topic
KW - Risk Factors
KW - Europe
KW - Reproducibility of Results
KW - Lymphatic Metastasis
KW - Pelvis
KW - Predictive Value of Tests
KW - Prognosis
KW - Risk Assessment
KW - Neoplasm Staging
KW - Societies, Medical
KW - Calibration
KW - Neoplasm Grading
KW - Prostate-Specific Antigen/blood
KW - Nomograms
KW - Prostatectomy
KW - Tumor Markers, Biological/blood
KW - Lymph Node Excision
KW - Confounding Factors (Epidemiology)
KW - Lymph Nodes/pathology
KW - Prostatic Neoplasms/immunology/pathology/surgery
U2 - 10.1016/j.ejso.2012.04.005
DO - 10.1016/j.ejso.2012.04.005
M3 - SCORING: Journal article
C2 - 22531769
VL - 38
SP - 624
EP - 629
JO - EJSO-EUR J SURG ONC
JF - EJSO-EUR J SURG ONC
SN - 0748-7983
IS - 7
M1 - 7
ER -